Apollomics Inc. Form 6-K Summary
Business context and reporting period
Apollomics Inc., a foreign private issuer, filed a Form 6-K for January 2024. On January 19, 2024, the company issued a press release concerning a Nasdaq minimum closing bid price compliance notice.
Key financial metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating and financial metrics.
Material changes versus the prior comparable period
The filing reports a Nasdaq notice regarding the requirement to maintain a minimum closing bid price of $1.00 per share. It does not provide comparative financial or operating information.
Guidance, outlook, risks, and unusual items
The filing does not state whether the company was in or out of compliance, identify any cure period, or describe potential consequences or remediation actions. The referenced press release is furnished as Exhibit 99.1, but its detailed contents are not included in the provided filing text.
Important facts to verify
- Review Exhibit 99.1 for the exact Nasdaq notice date, compliance status, cure period, and required actions.
- Verify whether Apollomics subsequently regained compliance or received any further Nasdaq notices.
- Assess any potential impact on the company’s Nasdaq listing and trading status.